Expression of CD70 and CD27 is also detected on malignant plasma cells in multiple myeloma, where CD27 decreases with increasing progression of the disease and its absence might even be a prognostic factor for high-risk disease [64, 65]. This evidence concerns the gene CD27 and AL amyloidosis.